Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Karam AK et al. - EDR assay results do not independently predict or alter the outcomes of patients with EOC who are treated with the current standards of primary cytoreductive surgery followed by platinum and taxane combination chemotherapy.

Related Articles

Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09    Relevance Score: 72%

Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
British Journal of Cancer, 11/02/09    Relevance Score: 70%

Unusual Metals Could Forge New Cancer Drug
ScienceDaily, 10/20/09    Relevance Score: 70%

New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09    Relevance Score: 70%

New drug aims to seek and destroy many types of cancer
EurekAlert, 10/06/09    Relevance Score: 70%